Evolus Inc. (EOLS)
EOLS trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$7.51
-3.10% on the day
Market cap
$496.0M
Small cap
Revenue · 2025
$297.2M
+11.6% on 2024
Net income · 2025
-$51.6M
-17.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | EOLS on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2018 |
| SEC CIK | 0001570562 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $297.2M |
| Net income | -$51.6M |
| Operating income | -$32.7M |
| Net margin | -17.4% |
| Operating margin | -11.0% |
| Revenue growth | +11.6% |
| Cash | $53.8M |
| Total assets | $225.9M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.7× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-06-05 |
| Latest annual report | 10-K | 2026-03-03 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-08-05 |
| Latest proxy | DEFA14A | 2026-04-29 |
Source: SEC EDGAR submissions feed, 555 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -5.8% |
| 1 month | -7.8% |
| 3 months | +29.5% |
| Year to date | +9.6% |
| 1 year | +21.5% |
| From 52-week high | -21.6% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BLSM | BlossomHill Therapeutics Inc. | $15.48 | -10.37% | $492.0M |
| DRUG | Bright Minds Biosciences Inc. | $51.36 | -4.91% | $504.3M |
| CTMX | CytomX Therapeutics Inc. | $2.33 | -3.93% | $506.6M |
| MNPR | Monopar Therapeutics Inc. | $72.08 | -6.45% | $483.8M |
| MPLT | MapLight Therapeutics Inc. | $7.88 | -8.43% | $510.1M |
| ACRS | Aclaris Therapeutics Inc. | $3.47 | -3.61% | $510.8M |
| CBIO | Crescent Biopharma Inc. | $12.91 | -10.72% | $479.5M |
| EVO | Evotec SE | $1.34 | -1.82% | $478.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier